Bio-Rad introduces Pioneer™ Antibody Discovery Platform for therapeutic development
HERCULES, Calif. — Bio-Rad Laboratories, Inc., a global leader in life science research and clinical diagnostic products, announces the launch of the Pioneer Antibody Discovery Platform, a new antibody discovery service specifically designed to develop best-in-class biologic candidates.
Arecor announces exclusive specialty hospital formulation collaboration
Arecor Therapeutics plc (AIM: AREC), the biopharmaceutical group advancing today’s therapies to enable healthier lives, today announces that it has signed an exclusive formulation study collaboration with the pharmaceutical division of one of the world’s largest chemicals marketing and pharmaceuticals companies, which focuses on the development and commercialisation of speciality drugs.
Q3 2022 results highlights strong performance from AstraZeneca
Latest results highlight more than $10 billion in product sales in Q3, taking the haul over $33bn in the year to date.
Four tips to effectively handle rising inflation rates
Barnes Commercial Insurance Broker says - read our tips on keeping your business afloat amongst current inflation rates and the increasing consumer price index
Breast cancer spread uncovered by new molecular microscopy
New technology can trace which populations of breast cancer cells are responsible for the spread of the disease, and for the first time highlights how the location of cancer cells could be as important as mutations in tumour growth.
Additional Bank Holiday for the King's Coronation
The government has confirmed that while the coronation will take place on Saturday 6th May, the following Monday, the 8th May 2023 will be a bank holiday to allow everyone to celebrate the special moment in history of His Majesty taking the throne. Do employers have to give their employees the day off?
Find out about alternative funding and finance for innovation
Alternative sources of funding and finance are ever changing. So, aside from grant funding, what is out there today that can help your innovation-driven business to grow and scale?
Pangaea Data awarded top tier co-sell partnership status by Microsoft
South San Francisco, USA - Pangaea Data, provider of a novel AI-driven product for characterizing patients by mapping their journeys and disease trajectories in a privacy-preserving and scalable manner, announces that it has been awarded top tier co-sell partnership status by Microsoft, its highest level partner designation. Microsoft has also extended this status by making Pangaea a transactable…
The UK’s biggest business survey is back and it’s time to make your voice heard
Cambridgeshire Chambers of Commerce's Quarterly Economic Survey is back and once again they are asking you to contribute to one of the UK’s largest and most reputable barometers of business opinion.
Ubiquigent appoints Dr Hozefa Amijee as Head of Business Development
Dundee, UK - Ubiquigent Limited, a drug discovery and development company harnessing novel deubiquitinase (DUB) modulators as new therapeutics for areas of high unmet medical need, announces the appointment of Dr Hozefa Amijee as Head of Business Development (BD).
The Epicentre in Haverhill celebrates buoyant second Birthday
The Epicentre in Haverhill is having a buoyant year as it has its second birthday this week with new companies signing up for space all the time and the full-up sign now being hung on all the laboratory space doors.
Alzheimer’s Research UK celebrates ‘Best Companies’ award
Cambridgeshire-based charity, Alzheimer's Research UK, has again been recognised as one of the Best Companies to work for in the East of England.
Optibrium and Lhasa Limited advance predictive modelling for drug-metabolising enzymes
Cambridge and Leeds – Optibrium and Lhasa Limited, two of the leading developers of software and artificial intelligence (AI) solutions for drug discovery and development, announces the publication of a peer-reviewed study in the Journal of Medicinal Chemistry.
How the cost of living crisis is impacting the mental wellbeing of your staff
Today (2 Nov) is Stress Awareness Day and next Monday (7 Nov) is the start of Stress Awareness Week - a time to highlight how stress can affect us and what we can do to manage it.
The Native Antigen Company expands its range of Omicron antigens to include BA.5 variant
New antigens support research into BA.5 variant, currently responsible for over half of global COVID-19 cases.
Close your open roles in 2022 with Biotech Search in 6-8 weeks
You've got time to secure talent before the holidays if you start now. We regularly work with UK Biotechs who need to supercharge their recruitment ... we guarantee our results with a 6-month free placement on your new hire.
Ellutia showcasing fully automated total nitrosamine testing system at Lab Innovations 2022
At Lab Innovations 2022, Ellutia will present the newest addition to its nitrosamine detection solutions, the Automated Total Nitrosamine Analyser (ATNA). The fully automated solution allows for rapid testing of apparent total nitrosamine content (ATNC) and has the right selectivity and sensitivity, so it can quickly identify whether or not nitrosamines are present down to 1ppb levels.
Ubiquigent obtains exclusive license for UbiSite technology to strengthen its specialist drug discovery services
Dundee, UK - Ubiquigent Limited (Ubiquigent), a drug discovery and development company harnessing novel deubiquitylase (DUB) modulators as new therapeutics for areas of high unmet medical need, has signed an exclusive license with the University of Southern Denmark for its UbiSite® technology.
Innovate UK EDGE prepares biotech client Bilitech for Investment
Bilitech Ltd a SME based in Cambridge has developed a technology to manufacture bioengineered bile ducts in the laboratory and aims to translate it to the clinic for use in patients. Bilitech specialises in the treatment of biliary disease, focusing on the use of bioengineered bile ducts.
Nuclera Nucleics Ltd grows and scale with support from Innovate UK EDGE support
With support from Innovate UK EDGE, biotech company Nuclera Nucleics were able to create a commercialisation plan, secured Series B funding and are on track to double their headcount by the end of 2022.
Wear it Pink!
Last week Corazon Health took part in 'Wear It Pink' event to raise much needed funds for Breast Cancer Now to help make life-saving breast cancer research and vital support happen.
Hospital charity’s surgical robot appeal reaches £1.5m target
Thousands more patients at Addenbrooke’s Hospital will benefit from the advantages of robotic surgery thanks to the support of local people who’ve helped raised £1.5 million to buy the hospital a new robot.
Cresset's October 2022 Newsletter
Read about Cresset's latest case studies, published papers, and upcoming events
Cambridge Filmworks produce a suite of new films for Genomics England
Genomics England mission is to turn science into healthcare, using technology – for everyone. They handle the huge quantities of data produced by genomic sequencing in the NHS, to improve patient treatment and empower research into new therapeutic discoveries. The Genomics England team is motivated by the challenge of the task, the desire to learn and by each other.